HomeAlternative Behavior StrategiesFirst Smartphone-based Digital Platform to Assist Autism Therapists Announced

First Smartphone-based Digital Platform to Assist Autism Therapists Announced

Alternative Behavior Strategies (ABS), a leading provider of services to children with autism spectrum disorders (ASD), today announced the launch of the ABS Virtual Office, the first smartphone-based platform to connect autism behavioral therapists to the information and knowledge they need—wherever they are—to enhance services and promote clinical excellence and advancement.

“The ABS Virtual Office is literally an office right in the palm of their hand,” said Adam Singer, M.D., CEO ABS. “The majority of our employees spend as much as 80 percent of their time in the field providing therapy, and we wanted to give them what they need to maintain the highest level of clinical excellence. Every employee in the company utilizes the ABS Virtual Office to connect to the company from wherever they may be working, client’s homes, clinics or schools. This platform gives therapists in the field real-time access to the electronic clinical record as well as to the collective wisdom of the company while treating a child, when this information is at its most vital. At any given time not only do they have access to the ABS collective repository of knowledge but live access to hundreds of other therapists that can assist.”

The ABS Virtual Office is for all ABS employees, clinical and non-clinical, giving them easy navigation to such features as:

  • ABS Chat—where ideas and questions can be shared with other ABS employees, including immediate clinical input from colleagues to help resolve timely issues that arise during therapy (for example, finding a dentist who treats autistic children)
  • Central Reach—provides direct access to the clinical records of a child’s treatment; as well as enables the clinical staff to bill and see the hours they have worked/converted in real time
  • Company and Industry News—including access to HR, their individual 401k, payroll and benefit information, community events, polls and other “stay in the know” information
  • Clinical innovation—Ideas are shared and debated on new and evolving therapeutic breakthroughs
  • Non-Clinical Staff—All ABS staff monitor the virtual office giving the clinicians real time access to any and all necessary support

The ABS Virtual Office is just one of many innovative strategies the company is implementing to continue its rapid growth while still maintaining clinical excellence.

“The demand for services for children with autism is exploding,” said David Fitzgerald, Partner, Petra Capital Partners, which, along with MMC Health Services, purchased ABS in 2017. “With this new digital platform, ABS is leading the industry in creating a communication platform for a highly mobile workforce in multiple states enabling these therapists to effectively communicate to share best practices, advice and improve quality. The result is a community focused on providing the best possible care to children with ASD.”

By providing stronger connections to the company and to clinical resources, the ABS Virtual Office will also serve as a retention tool to nurture an experienced team of clinicians.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy